# Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/concordance-between-the-response-evaluation-criteria-in-solid-tumors-version-1-1/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yuki Kataoka,Katsuya Hirano,Tomoko Narabayashi,Satoshi Hara,Daichi Fujimoto,Tae Tanaka,Noriyuki Ebi,Keisuke Tomii,Hiroshige Yoshioka |
| Citations | 10 |
| DOI | 10.1007/s00280-017-3498-z |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2771652751 |
| PMID | 29230503 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Tae Tanaka](https://scholariq.org/researchers/tae-tanaka/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Inflammatory Biomarkers in Disease Prognosis](https://scholariq.org/topics/inflammatory-biomarkers-in-disease-prognosis/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.